Early captopril treatment inhibits DNA synthesis in endothelial cells and normalization of maximal coronary flow in infarcted rat hearts

Cardiovascular Research

Volumn 40, Issue 1, 1998, Pages 156-164

  Nelissen Vrancken, H J Marjorie G ^a   Kuizinga, Marti C ^a   Daemen, Mat J A P ^a   Smits, Jos F M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Captopril; Coronary blood vessels; Endothelial cells; Myocardial infarction; Perindoprilat; Rat

Indexed keywords

ADENOSINE; CAPTOPRIL; NITROPRUSSIDE SODIUM; PERINDOPRILAT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CORONARY ARTERY BLOOD FLOW; DNA SYNTHESIS; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; HEART INFARCTION; HEART VENTRICLE REMODELING; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPTOPRIL; CORONARY CIRCULATION; DNA; DRUG IMPLANTS; ENDOTHELIUM, VASCULAR; INDOLES; MALE; MYOCARDIAL INFARCTION; PERFUSION; RATS; RATS, WISTAR; TIME FACTORS;

EID: 0032189755     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00127-8     Document Type: Article

References (46)

1. [1] Smits JFM, Passier RCJJ, Nelissen-Vrancken HJMG, Cleutjens JPM, Kuizinga MC, Daemon MJAP. Does ACE inhibition limit structural changes in the heart following myocardial infarction?. Eur Heart J 1995;16(Suppl. N):46-51.
2. [2] Anversa P, Beghi C, Kikkawa Y, Olivetti G. Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth. Circ Res 1986;58:26-37.
3. [3] van Krimpen C, Smits JFM, Cleutjens JPM, et al. DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril. J Mol Cell Cardiol 1991;23:1245-1253.
4. [4] Cleutjens JPM, Verluyten MJA, Smits JFM, Daemen MJAP. Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol 1995;147:325-338.
5. [5] Kuizinga MC, Cleutjens JPM, Smits JFM, Daemen MJAP. Griffonia simplicifolia I (GSI): a suitable rat cardiac microvascular marker on paraffin embedded tissue. J Mol Cell Cardiol 1992;24(Suppl. V):S57.
6. [6] Nelissen-Vrancken HJMG, Debets JJM, Schnoeckx LHEH, Daemen MJAP, Smits JFM. Time-related normalization of maximal coronary flow in isolated perfused hearts of rats with myocardial infarction. Circulation 1996;93:349-355.
7. [7] Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. J Clin Invest 1990;86:1913-1920.
8. [8] Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 1991;69:475-482.
9. [9] Studer R, Reinecke H, Muller B, Holtz J, Just H, Drexler H. Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction. J Clin Invest 1994;94:301-310.
10. [10] Passier RCJJ, Smits JFM, Verluyten MJA, Studer R, Drexler H, Daemen MJAP. Activation of angiotensin-converting-enzyme expression in the infarct zone following myocardial infarction. Am J Physiol 1995;269:H1268-H1276.
11. [11] Schoemaker RG, Debets JJM, Struyker-Boudier HAJ, Smits JFM. Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarction. J Mol Cell Cardiol 1991;23:187-197.
12. [12] Litwin SE, Litwin CM, Raya TE, Warner AL, Goldman S. Contractility and stiffness of noninfarcted myocardium after coronary ligation in rats. Effects of chronic angiotensin converting enzyme inhibition. Circulation 1991;83:1028-1037.
13. [13] Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 1985;72:406-412.
14. [14] Pfeffer MA, Pfeffer JM, Fishbein MC, et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979;44:503-512.
15. [15] Schoemaker RG, Debets JJM, Struyker-Boudier HAJ, Smits JFM. Beneficial hemodynamic effects of two weeks' milrinone treatment in conscious rats with heart failure. Eur J Pharmacol 1990;182:527-535.
16. [16] Snoeckx LHEH, Van der Vusse GJ, Coumans WA, Willemsen PHM, Van der Nagel T, Reneman RS. Myocardial function in normal and spontaneously hypertensive rats during reperfusion after a period of global ischaemia. Cardiovasc Res 1986;20:67-75.
17. [17] Wallenstein S, Zucker COL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980;47:1-9.
18. [18] Raya TE, Fonken SJ, Lee RW, et al. Hemodynamic effects of direct angiotensin II blockade compared to converting enzyme inhibition in rat model of heart failure. Am J Hypertens 1991;4:334S-340S.
19. [19] Hirsch AT, Talsness CE, Smith AD, Schunkert H, Ingelfinger JR, Dzau VJ. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure. Circulation 1992;86:1566-1574.
20. [20] Litwin SE, Raya TE, Warner A, Litwin CM, Goldman S. Effects of captopril on contractility after myocardial infarction: experimental observations. Am J Cardiol 1991;68:26D-34D.
21. [21] Bralet J, Marie C, Mossiat C, Lecomte J-M, Gros C, Schwartz J-C. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril. J Pharmacol Exp Ther 1994;270:8-14.
22. [22] Bélichard P, Savard P, Cardinal R, et al. Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias. J Am Coll Cardiol 1994;23:505-513.
23. [23] Regan CP, Anderson PG, Bishop SP, Berecek KH. Captopril prevents vascular and fibrotic changes but not cardiac hypertrophy in aortic-banded rats. Am J Physiol 1996;271:H906-H913.
24. [24] Capasso JM, Anversa P. Mechanical performance of spared myocytes after myocardial infarction in rats: effects of captopril treatment. Am J Physiol 1992;263:H841-H849.
25. [25] Mill JG, Gomes APV, Carrara AB, Gomes MGS, Vassallo DV. Influence of chronic captopril therapy on the mechanical performance of the infarcted rat heart. Pharmacol Res 1994;29:77-88.
26. [26] Capasso JM, Li P, Meggs LG, Herman MV, Anversa P. Efficacy of angiotensin-converting enzyme inhibition and AT1 receptor blockade on cardiac pump performance after myocardial infarction in rats. J Cardiovasc Pharmacol 1994;23:584-593.
27. [27] Metsärinne KP, Stoll M, Gohlke P, Paul M, Unger T. Angiotensin II is antiproliferative for coronary endothelial cells in vitro. Pharm Pharmacol Lett 1992;2:150-152.
28. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995;95:651-657.
29. [29] Kuizinga MC, Smits JFM, Arends JW, Daemen MJAP. AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction. J Mol Cell Cardiol 1998; in press.
30. [30] Vitullo JC, Penn MS, Rakunsan K, Wicker P. Effects of hypertension and aging on coronary arteriolar density. Hypertension 1993;21:406-414.
31. [31] Tomanek RJ. Capillary and pre-capillary coronary vascular growth during left ventricular hypertrophy. Can J Physiol Pharmacol 1986;2:114-119.
32. [32] Anversa P, Ricci R, Olivetti G. Coronary capillaries during normal and pathological growth. Can J Physiol Pharmacol 1986;2:104-113.
33. [33] Mall G, Zimmer G, Baden S, Mattfeldt T. Capillary neoformation in the rat heart-stereological studies on papillary muscles in hypertrophy and physiologic growth. Basic Res Cardiol 1990;85:531-540.
34. [34] Tomanek RJ, Schalk KA, Marcus ML, Harrison DG. Coronary angiogenesis during long-term hypertension and left ventricular hypertrophy in dogs. Circ Res 1989;65:352-359.
35. [35] O'Keefe DD, Hoffman JIE, Cheitlin R, O'Neill MJ, Allard JR, Shapkin E. Coronary blood flow in experimental canine left ventricle hypertrophy. Circ Res 1978;43:43-51.
36. [36] Motz W, Strauer BE. Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension 1996;27:1031-1038.
37. [37] Unger T, Mattfeldt T, Lamberty V, et al. Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries. Hypertension 1992;20:478-482.
38. [38] Wang D-H, Prewitt RL. Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension 1990;15:68-77.
39. [39] Le Noble FAC, Hekking JWM, Van Straaten HWM, Slaaf DW, Struyker-Boudier HAJ. Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur J Pharmacol 1991;195:305-306.
40. [40] Fernandez LA, Caride VJ, Twickler J, Galardy RE. Renin-angiotensin and development of collateral circulation after renal ischemia. Am J Physiol 1982;243:H869-H875.
41. [41] Fernandez LA, Twickler J, Mead A. Neovascularization produced by angiotensin II. J Lab Clin Med 1985;105:141-145.
42. [42] Munzenmaier DH, Greene AS. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension 1996;27:760-765.
43. [43] Nelissen-Vrancken HJMG, Struijker-Boudier HAJ, Daemen MJAP, Smits JFM. Antihypertensive therapy and adaptive mechanisms in peripheral ischemia. Hypertension 1993;22:780-788.
44. [44] Ziehe M, Parenti A, Morbidelli L, Meiniger CJ, Granger HJ, Ledda F. The effect of vasoactive factors on the growth of coronary endothelial cells. Cardiologia 1992;37:573-575.
45. [45] Gohlke P, Kuwer I, Schnell A, Amann K, Mall G, Unger T. Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats. Hypertension 1997;29:478-482.
46. [46] Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj J, Sorg C. Macrophages and angiogenesis. J Leukoc Biol 1994;55:410-422.